DCF — BAPTIST MEDICAL CTR-NASSAU
Enterprise Value: $1.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.4M
Enterprise Value
$-1.8M
PV of Cash Flows
$3.2M
PV of Terminal Value
$5.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $87.6M | $2.3M | 3.0% | $-1.5M | $-1.3M |
| Year 2 | $90.2M | $3.2M | 4.0% | $-0.8M | $-0.7M |
| Year 3 | $92.9M | $4.3M | 5.0% | $-0.2M | $-0.1M |
| Year 4 | $95.7M | $4.9M | 5.0% | $0.2M | $0.1M |
| Year 5 | $98.6M | $5.2M | 5.0% | $0.4M | $0.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.4M. Terminal value accounts for 224% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$85.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.020742942202161222
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5